Fundraising FoxShangBay Capital LLC — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)in
Co-investorsAbstract VenturesArtis VenturesFJ LabsJ12 VenturesStella CapitalAccel+23 more
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesJoyance PartnersLumira VenturesUS Venture PartnersAmzak HealthU.S. Venture Partners
SoundHealth develops FDA 510(k) cleared, drug-free medical devices that use acoustic resonance therapy via forehead bone conduction to treat nasal congestion and improve sleep.
AI & Machine LearningDigital HealthMedical Devices
Paramesh Gopi, PhD(Founder & CEO)Bryant Lin, MD, MEng(Founder & Head of Clinical Affairs and Product Design)Peter Hwang, MD(Founder & Head of Research)
Co-investorsG Vision CapitalJ4 VenturesMoai CapitalTau VenturesxNova VC (Aries)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.